| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |